Prodotti Ginecologia

Una linea di Prodotti studiata per fornire un delicato approccio al trattamento di Infiammazioni e Infezioni delle vie urinarie, per prevenire e trattare problematiche di Insufficienza circolatoria, microcircolatoria, stasi venosa e crisi emorroidaria, per la delicata Detersione cutanea e Igiene intima, e per fornire un’ottimale Idratazione e Protezione della cute nella donna in gravidanza e non.










RSS American Journal of Obstetrics & Gynecology

  • AJOG GR Table of Contents Agosto 1, 2024
  • Information for readers Agosto 1, 2024
  • AJOG MFM Table of Contents Agosto 1, 2024
  • Table of Contents Agosto 1, 2024
  • SMFM Divider Page Agosto 1, 2024
  • A United States stillbirth prevention bundle Agosto 1, 2024
    The stillbirth rate in the United States is considerably higher than in many countries with similar resources.1–3 In 2021, the United States stillbirth (loss before birth at ≥20 weeks’ gestation) ratio was 5.73 per 1000 births or 1 in 175 pregnancies with 21,000 stillbirths occurring annually.3 For example, in 2021, the late stillbirth rate (>28 […]
    Robert M. Silver, Joanne L. Stone
  • Successful eradication of group B Streptococcus intraamniotic infection with antibiotics in preterm prelabor rupture of the membranes Luglio 25, 2024
    Intraamniotic infection, a major cause of the preterm labor syndrome, is a risk factor for neonatal morbidity and mortality as well as long-term handicap.1 The frequency of intraamniotic infection in preterm prelabor rupture of the membranes (PPROM) is 40%.2 Common microorganisms found in the amniotic cavity of patients with PPROM include Sneathia species, Ureaplasma spp., […]
    Puntabut Warintaksa, Roberto Romero, Pisut Pongchaikul, Pornpun Vivithanaporn, Arun Meyyazhagan, Bo Hyun Yoon, Arunee Singsaneh, Piya Chaemsaithong
  • Corrigendum Luglio 25, 2024
    The authors of the articles listed below regret that there have been instances where the terms progesterone and 17α-hydroxyprogesterone caproate (17-OHCP or 17P) have been used interchangeably. To clarify, the terminology in the following publications have been amended and the online versions are now corrected.
  • Introduction of a nationwide first-trimester anomaly scan in the Dutch national screening program Luglio 25, 2024
    A significant proportion of major fetal structural anomalies can be detected in the first trimester by ultrasound examination. However, the test performance of the first-trimester anomaly scan (FTAS) performed in a low-risk population as part of a nationwide prenatal screening program is unknown. Potential benefits of the FTAS include early detection of fetal anomalies, providing […]
    Eline E.R. Lust, Kim Bronsgeest, Lidewij Henneman, Neeltje Crombag, Caterina M. Bilardo, Robert-Jan H. Galjaard, Esther Sikkel, Sanne van der Hout, Audrey Coumans, Ayten Elvan-Taşpınar, Attie T.J.I. Go, Sander Galjaard, Gwendolyn T.R. Manten, Eva Pajkrt, Liesbeth van Leeuwen, Monique C. Haak, Mireille N. Bekker
  • Zebras in a Snowstorm: Ultrasound guidance for differentiating placental mesenchymal dysplasia from hydatidiform mole. Luglio 25, 2024
    Nicholas B. LOLLI, Amanda M. MCWHIRTER, Karen B. LESSER, Demaretta S. RUSH, Ahmed G. ABOUL-NASR, Lynn M. COPPOLA
  • Racial and ethnic disparities in reproductive medicine in the United States: A narrative review of contemporary high-quality evidence Luglio 24, 2024
    There has been increasing debate around how or if race and ethnicity should be used in medical research—including the conceptualization of race as a biological entity, a social construct, or a proxy for racism. The objectives of this narrative review are to identify and synthesize reported racial and ethnic inequalities in obstetrics and gynecology (ob/gyn) […]
    Ayodele G. LEWIS, Divya K. SHAH, Regina LEONIS, John REES, Katharine F.B. CORREIA
  • Publication of the ARRIVE Trial and Changes in Early Term Induction of Labor Luglio 24, 2024
    Taylor S. FRERET, Anjali J. KAIMAL, Alexander MELAMED, Mark A. CLAPP
  • The fibroid crisis in Black women: more work to be done! Luglio 24, 2024
    Although prevalent among all women, uterine fibroids are uniquely pernicious in Black women, who experience significantly higher rates, with earlier onset and more complex disease. Epitomized by the biopsychosocial model, the root causes of these disparities in prevalence, symptoms, and outcomes are numerous and multifaceted, and they are at the intersection of biological constructs and […]
    Rachel Michel, Wanda K. Nicholson, Mostafa A. Borahay
  • HOT FLASHES AND SLEEP DISRUPTION IN A RANDOMIZED TRIAL IN MENOPAUSAL WOMEN Luglio 20, 2024
    Hot flashes, common during menopause, affect up to 80% of Western menopausal women and are reported to contribute to sleep disturbances in midlife. Few prospective data are available to confirm the specific role of hot flashes in disrupting sleep in midlife women, however, or confirm whether changes in hot flashes in response to clinical therapies […]
    Mingzhuo PEI, Carolyn J. GIBSON, Michael SCHEMBRI, Harini RAGHUNATHAN, Deborah GRADY, Peter GANZ, Alison J. HUANG
  • Prevention of postpartum hemorrhage is essential for patients with placental diseases after hysteroscopic adhesiolysis Luglio 18, 2024
    We read with interest the article published in May 2024 by Mortimer et al,1 which focused on pregnancy complications and neonatal outcomes of in vitro fertilization (IVF) pregnancies in patients treated for intrauterine adhesions (IUAs) by hysteroscopy. This retrospective study found that patients who underwent hysteroscopic adhesiolysis (HA) are at considerably increased risk of placental diseases, such […]
    Yongdan Ma, Jingmei Ma